香港奥博医疗资本有限公司上海代表处

Established in 1989, OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm. OrbiMed manages approximately USD$13 billion assets and has invested in over 450 companies across a wide range of therapeutic categories and stages of development.
OrbiMed Asia manages three Asia-focused PE/VC funds, totaling over $1 billion. It has made investments in 36 companies. OrbiMed’s public equity funds have invested approximately USD$2 billion in Asia public companies.
Our Shanghai office is located at People’s Square, Huangpu district. You can find more detailed information from our website: ww***com[点击查看]

奥博资本(OrbiMed)创立于1989年，是全球最大的专注于生物医疗领域的投资公司,目前管理约130亿美元的资产，在全球成功投资了450多家企业。奥博资本致力于寻找和支持能够促进人类健康的生物医疗和生命科学企业。我们专注于全球生物医疗领域的投资已有二十多年，投资项目涵盖生物制药、生命科技、医疗器械、医疗服务及诊断等领域，投资阶段覆盖初创期、成长期、成熟期及上市后。更多信息请见ww***com[点击查看]